STEVEN LEE WALLENTINE
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PROVO, UT NPI 1790736122
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology UT PFIZER INC. All categories
General Payments — all program years on this page
$7,428.04
- Category: General Payments
- Program years: PY2018–2024
- Record count: 452
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,026.95 across 53 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,026.95 | 53 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $161.27 | 12 |
| EMD Serono, Inc. | $111.10 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $106.15 | 5 |
| Merck Sharp & Dohme Corporation | $90.57 | 3 |
| GENZYME CORPORATION | $85.06 | 3 |
| Acerta Pharma LLC | $82.21 | 4 |
| ARRAY BIOPHARMA INC | $52.99 | 4 |
| GlaxoSmithKline, LLC. | $48.01 | 3 |
| Daiichi Sankyo Inc. | $47.13 | 2 |
| Astellas Pharma US Inc | $46.86 | 2 |
| Exelixis Inc. | $25.82 | 1 |
| Coherus Biosciences Inc. | $23.52 | 1 |
| Deciphera Pharmaceuticals Inc. | $21.37 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.97 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $19.12 | 1 |
| Fennec Pharmaceuticals, Inc. | $18.93 | 1 |
| Lilly USA, LLC | $16.86 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.79 | 1 |
| PharmaEssentia USA Corporation | $16.22 | 1 |
| Sumitomo Pharma America, Inc. | $16.00 | 1 |
By program year
Records — PY2024 (53)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.